{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-008273","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2022-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.386078+00:00","generated_at":"2026-06-27T02:32:19.036105+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Graphite Bio hires Alethia Young as CFO; Gutry steps down as PFO/PAO","bullets":["Alethia Young appointed CFO effective April 1, 2022; previously senior biotech analyst at Cantor Fitzgerald.","Base salary $450,000, target cash bonus 40% of salary, signing bonus $170,000.","Relocation assistance $50,000/quarter for 12 months; initial option grant of 350,000 shares.","Philip Gutry resigns as principal financial officer and principal accounting officer effective April 1, remains Chief Business Officer.","Ms. Young will oversee finance, investor relations, corporate communications, and corporate strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-008273","json":"https://secwatch.observer/filing/0001564590-22-008273.json","markdown":"https://secwatch.observer/filing/0001564590-22-008273.md","text":"https://secwatch.observer/filing/0001564590-22-008273.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000156459022008273/0001564590-22-008273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000156459022008273/grph-8k_20220302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:32:19.036105+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b8fc8d2ae","claim":"Alethia Young was appointed as Chief Financial Officer at LENZ Therapeutics, Inc..","evidence_excerpt":"On March 2, 2022, Graphite Bio, Inc. (the “Company”) announced the hiring and appointment of Alethia Young as Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815776/000156459022008273/0001564590-22-008273-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a286e4ece2","claim":"Philip P. Gutry resigned as principal financial officer and principal accounting officer at LENZ Therapeutics, Inc..","evidence_excerpt":"Effective as of April 1, 2022, Philip P. Gutry, who is currently serving as Chief Business Officer, Head of Finance & Investor Relations, principal financial officer and principal accounting officer of the Company, will resign from his positions as the Company’s Head of Finance & Investor Relations, principal financial officer and principal accounting officer and will continue to serve as Chief Business Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815776/000156459022008273/0001564590-22-008273-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"principal financial officer and principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}